Results 11 to 20 of about 60,195 (236)

Metastatic urothelial carcinoma

open access: yesAnais Brasileiros de Dermatologia, 2021
A 61-year-old-man of the South of Spain presented at the Dermatology Department at Hospital Regional Universitario de Malaga with multiple painful erythemato-violaceous nodules on the chin, on the trunk, and the scalp (Fig. 1). The patient had been diagnosed with muscle-invasive micropapillary bladder cancer one year before and received treatment with ...
Elisabeth Gómez-Moyano   +3 more
openaire   +8 more sources

The Value of Insulin-like Growth Factor 2 in Urinary Exosomes of Bladder Urothelial Carcinoma

open access: yesXiehe Yixue Zazhi, 2022
Objective  To explore the expression of insulin-like growth factor 2 (IGF2) in urinary exosomes of patients with bladder urothelial carcinoma, and to evaluate its clinical value in the diagnosis of bladder urothelial carcinoma.
YANG Tingkai, WEN Jin, JI Zhigang
doaj   +1 more source

Detection of Canine Urothelial Carcinoma Cells in Urine Using 5-Aminolevulinic Acid

open access: yesAnimals, 2022
This study aimed to establish a method to detect canine urothelial carcinoma cells in urine using 5-aminolevulinic acid (5-ALA) and to evaluate its diagnostic accuracy.
Kenjiro Kaji   +3 more
doaj   +1 more source

CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma

open access: yesFrontiers in Oncology, 2021
IntroductionCircular RNAs (circRNAs) are non-coding RNAs that have the structure of a covalently closed loop. Increasing data have proven that circRNAs can influence the progression and chemotherapy sensitivity of tumors.
Jiancheng Lv   +11 more
doaj   +1 more source

Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas

open access: yesTürk Patoloji Dergisi, 2021
Objective: Micropapillary urothelial carcinoma is an aggressive variant of urothelial carcinoma. Evidence suggests that the relationship between the tumor and inflammatory cells is important in tumor progression and the treatment response.
Ezgi HACIHASANOĞLU   +3 more
doaj   +1 more source

Prognostic and Diagnostic Significance of Platelet Indices in Patients with Urothelial Carcinoma

open access: yesUro, 2021
Some prognostic markers have been shown to determine the course and survival of Urothelial Cancer. A cross-sectional retrospective study, specifically looking at the role that various indices related to platelets—namely Mean Platelet Volume (MPV ...
Gulshan Kumar Mukhiya   +3 more
doaj   +1 more source

The Role of MMP-9 and VEGF in the Invasion State of Bladder Urothelial Carcinoma

open access: yesIndonesian Biomedical Journal, 2021
BACKGROUND: Bladder cancer is the tenth-most common cancer in worldwide and the majority are urothelial carcinomas. The depth of invasion plays important role in the prognostic and therapeutic factor in urothelial carcinomas.
Novalia Chumaladewi Guntarno   +2 more
doaj   +1 more source

A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report

open access: yesFrontiers in Oncology, 2021
The prognosis of patients with advanced urothelial carcinoma is dismal. Platinum-based chemotherapy is still the main first-line treatment for advanced urothelial carcinoma, while immunotherapy can be used as a first-line treatment option for people who ...
Jianzheng Wang   +9 more
doaj   +1 more source

Urothelial carcinoma in a child [PDF]

open access: yesArchivos Españoles de Urología (Ed. impresa), 2005
Urothelial carcinoma of the bladder occurs rarely in the first 2 decades of life. We report a case of a 12 year-old child that presented with a Ta grade II/III urothelial carcinoma of the bladder.We describe its clinical presentation and diagnostic procedures as well as treatment and follow-up. Finally, we review the literature to analyze the etiology,
Rodriguez, Alejandro   +4 more
openaire   +4 more sources

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma

open access: yesFrontiers in Oncology, 2022
BackgroundInfiltrating bladder urothelial carcinoma is the most common bladder malignancy with limited therapeutic options and poor prognosis. Identifying new therapeutic targets or strategies has important clinical significance.
Ran Sun   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy